MKI67 and glioblastoma: The brains were fixed and sectioned then stained for Ki67 to label proliferating glioblastoma cells within the nonproliferative brain tissue, using a previously validated method (via correlation with human leukocyte antigen for quantifying invasion.5 Subsequent automated analysis revealed that invasion was significantly decreased in mice treated with ATRi (Figure 6B(ii)).